Accelevir Diagnostics LLC
Baltimore, MD Part of AGI Scientific, LLC
- UEI
- F6SKM7YHCUS7
- CAGE
- 7FL22
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- NAICS codes registered in SAM.gov
- Corporate family
-
-
AGI Scientific, LLC
Parent
UVMQCN4KA4J9
- Accelevir Diagnostics LLC F6SKM7YHCUS7
-
AGI Scientific, LLC
Parent
UVMQCN4KA4J9
- SAM.gov registration date
- Physical address
- 701 E Pratt St #4016, Baltimore, MD 21202, USA
- Website
- accelevirdx.com
- Founded
- 2015
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Accelevir Diagnostics LLC
Accelevir Diagnostics LLC is a woman-owned small business that provides research and development services related to HIV diagnostics and measurement of the HIV latent reservoir. The company has developed proprietary technology for HIV testing and measurement, including the intact proviral DNA assay (IPDA) for quantification of intact and defective HIV proviruses.
Through prime contract awards, Accelevir Diagnostics has provided research and development of enhanced diagnostics to support global HIV cure and clinical trials, including adapting the IPDA to enable measurement of latent HIV-1 for individuals with subtype CRF-1_AE. These contracts were awarded by the Department of Health and Human Services' National Institutes of Health and National Institute of Allergy and Infectious Diseases, with total potential values up to $2 million. The contracts were set aside for total small businesses. Accelevir Diagnostics has also provided custom DNA assay analysis for the National Institute of Allergy and Infectious Diseases through a $13,500 purchase order contract.
Through prime grant awards, Accelevir Diagnostics has received funding to develop the HIV-1 ENVLRS assay to assess HIV-1 broadly neutralizing antibody resistance and predict efficacy. Additional grants have supported expanding the IPDA to cover HIV-1 subtype C to enable global eradication trials, as well as resources to quantify latent and expressed HIV reservoirs. These awards have been provided by the National Institute of Allergy and Infectious Diseases, with total potential funding over $10 million.
Quick answers
What is Accelevir Diagnostics LLC's UEI?
Accelevir Diagnostics LLC's Unique Entity ID (UEI) in SAM.gov is F6SKM7YHCUS7.
What is Accelevir Diagnostics LLC's CAGE code?
Accelevir Diagnostics LLC's CAGE code is 7FL22.
What is Accelevir Diagnostics LLC's primary NAICS code?
Accelevir Diagnostics LLC's primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Accelevir Diagnostics LLC located?
Accelevir Diagnostics LLC's physical address in SAM.gov is 701 E Pratt St #4016, Baltimore, MD 21202, USA.
Is Accelevir Diagnostics LLC registered in SAM.gov?
Yes. Accelevir Diagnostics LLC's SAM.gov registration is active through February 10, 2027.
Who is Accelevir Diagnostics LLC's parent company?
Accelevir Diagnostics LLC is part of AGI Scientific, LLC.
What is Accelevir Diagnostics LLC's most recent federal award?
Accelevir Diagnostics LLC's most recent federal contract award is Proviral sequencing driven development of enhanced IPDAV2 with global HIV-1 group m coverage to support worldwide cure… (75N93023C00017), from National Institute of Allergy and Infectious Diseases, on June 1, 2023.
On GovTribe
See Accelevir Diagnostics LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors